Baihakke, Norsina S.

HRN: 23-99-19  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/13/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
09/13/2024
09/20/2024
IV
600mg
Q6
Cellulitis
Waiting Final Action 
09/17/2024
CLINDAMYCIN 300MG (CAP)
09/17/2024
09/24/2024
PO
300mg
TID
Cellulitis
Waiting Final Action 
09/18/2024
CLINDAMYCIN 300MG (CAP)
09/18/2024
09/25/2024
ORAL
300mg/cap
Q6H
Cellulitis
Waiting Final Action 
09/18/2024
CEFTAZIDIME 1GM (VIAL)
09/18/2024
09/25/2024
IV
2g
OD
Sepsis; Cellulitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: